Found 144 clinical trials
COVID-19 and Cancer Patients
Routinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.
- 0 views
- 01 Feb, 2023
- 1 location
Norwegian SARS-CoV-2 Study - Virological Clinical and Immunological Characterisation of COVID-19
Oslo University Hospital has initiated an observational study on hospitalised patients with confirmed COVID-19, the infection caused by Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2).
- 0 views
- 16 Feb, 2024
- 7 locations
Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis
CovidSurg-Cancer is an international, multicentre, observational cohort study designed to evaluate the 30-day COVID-19 infection rates in elective cancer surgery during the COVID-19 pandemic. Centres can elect to include one or more cancer types in the study, in any combination, depending on local expertise and capacity. During the pilot study, …
- 0 views
- 16 Feb, 2024
- 1 location
Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic
Observational, cross-sectional, multi-center, multi-wave survey, assessing characteristics and predictors of physical and mental health as well as health behaviors during COVID-19 pandemic, targeting the general population (children, adolescents and adults).
- 0 views
- 05 Aug, 2020
Italian Web-based Cross-sectional Survey on COVID-19
The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that started in late December 2019 in the Hubei province of China caused millions of cases worldwide in just a few months, and evolved into a real pandemic. However, only approximately 20% of SARS-CoV-2 infected patients required intensive on sub-intensice …
- 0 views
- 16 Feb, 2024
- 1 location
Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome
To ascertain globally the changes in the cytokines involved and TLRs/KIR activation in patients admitted to the hospital with a COVID-19 diagnosis, and the changes after initiation of the different therapies
- 0 views
- 16 Feb, 2024
- 1 location
Imaging Feature of SARS-CoV2 Infection
The novel coronavirus SARS-CoV2 clinically presents with pneumonia, characterised by fever, cough, dyspnea. The severity of the disease varies widely with evidence of mild disease in the majority of confirmed cases, severe pneumonia-dyspnea, hypoxia or lung involvement at imaging within 24-48 hours- and critical disease with respiratory failure, shock or …
- 0 views
- 16 Feb, 2024
- 1 location
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches
On progression of the disease, bacterial superinfection facilitated by inflammation and virus related damage, has been identified as the main factor for patient outcome, but the role of the host versus the environment microbiome remains unclear.
- 0 views
- 16 Feb, 2024
- 1 location
Asthma: Phenotyping Exacerbations 2
We aim to describe exacerbation profiles (phenotypes) of the cohort in terms of inflammatory/biomarker profile and bacterial/viral infection status and to compare these with exacerbation events in the sister APEX cohort.
- 0 views
- 16 Feb, 2024
- 1 location
Asthma: Phenotyping EXacerbations
We aim to describe exacerbation profiles (phenotypes) of the cohort in terms of inflammatory/biomarker profile and bacterial/viral infection status and to compare these with exacerbation events in the sister APEX cohort.
- 0 views
- 16 Feb, 2024
- 1 location